BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 22, 2023 (GLOBE NEWSWIRE) -- Roivant Sciences (ROIV) today announced positive results from the chronic period of the TUSCANY-2 Phase 2b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback